Paper39296804
Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines.
Gautam M and 1 other. Bioimpacts, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines. Papers, record 39296804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39296804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35267408 | Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267408 | PubMed |
| 2 | 23545416 | Caspase functions in cell death and disease. | Cold Spring Harb Perspect Biol | 2013 | https://conductscience.org/library/papers/23545416 | PubMed |
| 3 | 35159037 | Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35159037 | PubMed |
| 4 | 19465777 | d -Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis. | J Carcinog | 2009 | https://conductscience.org/library/papers/19465777 | PubMed |
| 5 | 16928301 | [Effects of D-limonene on leukemia cells HL-60 and K562 in vitro]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2006 | https://conductscience.org/library/papers/16928301 | PubMed |
| 6 | 29259986 | Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/29259986 | PubMed |
| 7 | 29848900 | Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells. | Biol Pharm Bull | 2018 | https://conductscience.org/library/papers/29848900 | PubMed |
| 8 | 34065960 | Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34065960 | PubMed |
| 9 | 25045784 | Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803. | J Med Food | 2014 | https://conductscience.org/library/papers/25045784 | PubMed |
| 10 | 35361964 | Cell cycle regulation: p53-p21-RB signaling. | Cell Death Differ | 2022 | https://conductscience.org/library/papers/35361964 | PubMed |
| 11 | 35768332 | Benzyl Isothiocyanate-Induced Cytotoxicity via the Inhibition of Autophagy and Lysosomal Function in AGS Cells. | Biomol Ther (Seoul) | 2022 | https://conductscience.org/library/papers/35768332 | PubMed |
| 12 | 28454256 | High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates. | Oncol Lett | 2017 | https://conductscience.org/library/papers/28454256 | PubMed |
| 13 | 34337348 | Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. | Cancer Drug Resist | 2021 | https://conductscience.org/library/papers/34337348 | PubMed |
| 14 | 33348858 | Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies. | Cells | 2020 | https://conductscience.org/library/papers/33348858 | PubMed |
| 15 | 21455968 | Critical aspects in analysis of cellular DNA content. | Curr Protoc Cytom | 2011 | https://conductscience.org/library/papers/21455968 | PubMed |
| 16 | 25681668 | The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. | Cancer Lett | 2015 | https://conductscience.org/library/papers/25681668 | PubMed |
| 17 | 31482470 | Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells. | Apoptosis | 2019 | https://conductscience.org/library/papers/31482470 | PubMed |
| 18 | 25663820 | N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87. | Cancer Cell Int | 2014 | https://conductscience.org/library/papers/25663820 | PubMed |
| 19 | 32168477 | Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma. | J Neurosurg | 2021 | https://conductscience.org/library/papers/32168477 | PubMed |
| 20 | 35806212 | Glioblastoma Treatment: State-of-the-Art and Future Perspectives. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806212 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39695017 | Current Combinatorial Therapeutic Aspects: The Future Prospect for Glioblastoma Treatment. | Curr Med Sci | 2024 | https://conductscience.org/library/papers/39695017 | PubMed |
| 39181940 | Chemical composition of essential and fixed oils of Tagetes erecta fruits (Iran) and their implications in inhibition of cancer signaling. | Sci Rep | 2024 | https://conductscience.org/library/papers/39181940 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39296804
GET https://conductscience.org/api/papers/v1/39296804/references?page=2